Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities

Laila Alrakaf, Mohammed A. Al-Owain, Maryam Busehail, Maha A. Alotaibi, Dorota Monies, Hesham M. Aldhalaan, Amal Alhashem, Zuhair N. Al-Hassnan, Zuhair A. Rahbeeni, Fathiya Al Murshedi, Nadia Al Ani, Almundher Al-Maawali, Niema A. Ibrahim, Firdous M. Abdulwahab, Maysoon Alsagob, Mais O. Hashem, Wafaa Ramadan, Mohamed Abouelhoda, Brian F. Meyer, Namik KayaSateesh Maddirevula, Fowzan S. Alkuraya

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Temtamy syndrome is a syndromic form of intellectual disability characterized by ocular involvement, epilepsy and dysgenesis of the corpus callosum. After we initially mapped the disease to C12orf57, we noted a high carrier frequency of an ancient startloss founder mutation [c.1A>G; p.M1?] in our population, and variable phenotypic expressivity in newly identified cases. This study aims to combine 33 previously published patients with 23 who are described here for the first time to further delineate the phenotype of this syndrome. In addition to the known p.M1? founder, we describe four novel homozygous variants, thus increasing the number of Temtamy syndrome-related C12orf57 variants to seven, all but one predicted to be loss of function. While all patients presented with intellectual disability/developmental delay, the frequency of other phenotypic features was variable: 73.2% (41/56) had epilepsy, 63% (34/54) had corpus callosal abnormalities, 14.5% (8/55) had coloboma, and 16.4% (9/55) had microphthalmia. Our analysis also revealed a high frequency of less recognized features such as congenital heart disease (51.4%), and brain white matter abnormalities (38%, 19/50). We conclude that C12orf57 variants should be considered in the etiology of developmental delay/intellectual disability, even when typical syndromic features are lacking, especially in those who trace their ancestry to Saudi Arabia where a founder C12orf57 mutation is among the most common recessive causes of intellectual disability.

Original languageEnglish
Pages (from-to)715-721
Number of pages7
JournalAmerican Journal of Medical Genetics, Part A
Volume176
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Eye Abnormalities
Corpus Callosum
Intellectual Disability
Epilepsy
Agenesis of Corpus Callosum
Coloboma
Microphthalmos
Mutation
Saudi Arabia
Heart Diseases
Phenotype
Temtamy syndrome
Brain
Population

Keywords

  • C12orf57
  • colobomav
  • global developmental delay
  • Temtamy syndrome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Alrakaf, L., Al-Owain, M. A., Busehail, M., Alotaibi, M. A., Monies, D., Aldhalaan, H. M., ... Alkuraya, F. S. (2018). Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities. American Journal of Medical Genetics, Part A, 176(3), 715-721. https://doi.org/10.1002/ajmg.a.38615

Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities. / Alrakaf, Laila; Al-Owain, Mohammed A.; Busehail, Maryam; Alotaibi, Maha A.; Monies, Dorota; Aldhalaan, Hesham M.; Alhashem, Amal; Al-Hassnan, Zuhair N.; Rahbeeni, Zuhair A.; Murshedi, Fathiya Al; Ani, Nadia Al; Al-Maawali, Almundher; Ibrahim, Niema A.; Abdulwahab, Firdous M.; Alsagob, Maysoon; Hashem, Mais O.; Ramadan, Wafaa; Abouelhoda, Mohamed; Meyer, Brian F.; Kaya, Namik; Maddirevula, Sateesh; Alkuraya, Fowzan S.

In: American Journal of Medical Genetics, Part A, Vol. 176, No. 3, 01.03.2018, p. 715-721.

Research output: Contribution to journalArticle

Alrakaf, L, Al-Owain, MA, Busehail, M, Alotaibi, MA, Monies, D, Aldhalaan, HM, Alhashem, A, Al-Hassnan, ZN, Rahbeeni, ZA, Murshedi, FA, Ani, NA, Al-Maawali, A, Ibrahim, NA, Abdulwahab, FM, Alsagob, M, Hashem, MO, Ramadan, W, Abouelhoda, M, Meyer, BF, Kaya, N, Maddirevula, S & Alkuraya, FS 2018, 'Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities', American Journal of Medical Genetics, Part A, vol. 176, no. 3, pp. 715-721. https://doi.org/10.1002/ajmg.a.38615
Alrakaf L, Al-Owain MA, Busehail M, Alotaibi MA, Monies D, Aldhalaan HM et al. Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities. American Journal of Medical Genetics, Part A. 2018 Mar 1;176(3):715-721. https://doi.org/10.1002/ajmg.a.38615
Alrakaf, Laila ; Al-Owain, Mohammed A. ; Busehail, Maryam ; Alotaibi, Maha A. ; Monies, Dorota ; Aldhalaan, Hesham M. ; Alhashem, Amal ; Al-Hassnan, Zuhair N. ; Rahbeeni, Zuhair A. ; Murshedi, Fathiya Al ; Ani, Nadia Al ; Al-Maawali, Almundher ; Ibrahim, Niema A. ; Abdulwahab, Firdous M. ; Alsagob, Maysoon ; Hashem, Mais O. ; Ramadan, Wafaa ; Abouelhoda, Mohamed ; Meyer, Brian F. ; Kaya, Namik ; Maddirevula, Sateesh ; Alkuraya, Fowzan S. / Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities. In: American Journal of Medical Genetics, Part A. 2018 ; Vol. 176, No. 3. pp. 715-721.
@article{d8484b6b553a4d868fcf8537628ab36e,
title = "Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities",
abstract = "Temtamy syndrome is a syndromic form of intellectual disability characterized by ocular involvement, epilepsy and dysgenesis of the corpus callosum. After we initially mapped the disease to C12orf57, we noted a high carrier frequency of an ancient startloss founder mutation [c.1A>G; p.M1?] in our population, and variable phenotypic expressivity in newly identified cases. This study aims to combine 33 previously published patients with 23 who are described here for the first time to further delineate the phenotype of this syndrome. In addition to the known p.M1? founder, we describe four novel homozygous variants, thus increasing the number of Temtamy syndrome-related C12orf57 variants to seven, all but one predicted to be loss of function. While all patients presented with intellectual disability/developmental delay, the frequency of other phenotypic features was variable: 73.2{\%} (41/56) had epilepsy, 63{\%} (34/54) had corpus callosal abnormalities, 14.5{\%} (8/55) had coloboma, and 16.4{\%} (9/55) had microphthalmia. Our analysis also revealed a high frequency of less recognized features such as congenital heart disease (51.4{\%}), and brain white matter abnormalities (38{\%}, 19/50). We conclude that C12orf57 variants should be considered in the etiology of developmental delay/intellectual disability, even when typical syndromic features are lacking, especially in those who trace their ancestry to Saudi Arabia where a founder C12orf57 mutation is among the most common recessive causes of intellectual disability.",
keywords = "C12orf57, colobomav, global developmental delay, Temtamy syndrome",
author = "Laila Alrakaf and Al-Owain, {Mohammed A.} and Maryam Busehail and Alotaibi, {Maha A.} and Dorota Monies and Aldhalaan, {Hesham M.} and Amal Alhashem and Al-Hassnan, {Zuhair N.} and Rahbeeni, {Zuhair A.} and Murshedi, {Fathiya Al} and Ani, {Nadia Al} and Almundher Al-Maawali and Ibrahim, {Niema A.} and Abdulwahab, {Firdous M.} and Maysoon Alsagob and Hashem, {Mais O.} and Wafaa Ramadan and Mohamed Abouelhoda and Meyer, {Brian F.} and Namik Kaya and Sateesh Maddirevula and Alkuraya, {Fowzan S.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1002/ajmg.a.38615",
language = "English",
volume = "176",
pages = "715--721",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Further delineation of Temtamy syndrome of corpus callosum and ocular abnormalities

AU - Alrakaf, Laila

AU - Al-Owain, Mohammed A.

AU - Busehail, Maryam

AU - Alotaibi, Maha A.

AU - Monies, Dorota

AU - Aldhalaan, Hesham M.

AU - Alhashem, Amal

AU - Al-Hassnan, Zuhair N.

AU - Rahbeeni, Zuhair A.

AU - Murshedi, Fathiya Al

AU - Ani, Nadia Al

AU - Al-Maawali, Almundher

AU - Ibrahim, Niema A.

AU - Abdulwahab, Firdous M.

AU - Alsagob, Maysoon

AU - Hashem, Mais O.

AU - Ramadan, Wafaa

AU - Abouelhoda, Mohamed

AU - Meyer, Brian F.

AU - Kaya, Namik

AU - Maddirevula, Sateesh

AU - Alkuraya, Fowzan S.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Temtamy syndrome is a syndromic form of intellectual disability characterized by ocular involvement, epilepsy and dysgenesis of the corpus callosum. After we initially mapped the disease to C12orf57, we noted a high carrier frequency of an ancient startloss founder mutation [c.1A>G; p.M1?] in our population, and variable phenotypic expressivity in newly identified cases. This study aims to combine 33 previously published patients with 23 who are described here for the first time to further delineate the phenotype of this syndrome. In addition to the known p.M1? founder, we describe four novel homozygous variants, thus increasing the number of Temtamy syndrome-related C12orf57 variants to seven, all but one predicted to be loss of function. While all patients presented with intellectual disability/developmental delay, the frequency of other phenotypic features was variable: 73.2% (41/56) had epilepsy, 63% (34/54) had corpus callosal abnormalities, 14.5% (8/55) had coloboma, and 16.4% (9/55) had microphthalmia. Our analysis also revealed a high frequency of less recognized features such as congenital heart disease (51.4%), and brain white matter abnormalities (38%, 19/50). We conclude that C12orf57 variants should be considered in the etiology of developmental delay/intellectual disability, even when typical syndromic features are lacking, especially in those who trace their ancestry to Saudi Arabia where a founder C12orf57 mutation is among the most common recessive causes of intellectual disability.

AB - Temtamy syndrome is a syndromic form of intellectual disability characterized by ocular involvement, epilepsy and dysgenesis of the corpus callosum. After we initially mapped the disease to C12orf57, we noted a high carrier frequency of an ancient startloss founder mutation [c.1A>G; p.M1?] in our population, and variable phenotypic expressivity in newly identified cases. This study aims to combine 33 previously published patients with 23 who are described here for the first time to further delineate the phenotype of this syndrome. In addition to the known p.M1? founder, we describe four novel homozygous variants, thus increasing the number of Temtamy syndrome-related C12orf57 variants to seven, all but one predicted to be loss of function. While all patients presented with intellectual disability/developmental delay, the frequency of other phenotypic features was variable: 73.2% (41/56) had epilepsy, 63% (34/54) had corpus callosal abnormalities, 14.5% (8/55) had coloboma, and 16.4% (9/55) had microphthalmia. Our analysis also revealed a high frequency of less recognized features such as congenital heart disease (51.4%), and brain white matter abnormalities (38%, 19/50). We conclude that C12orf57 variants should be considered in the etiology of developmental delay/intellectual disability, even when typical syndromic features are lacking, especially in those who trace their ancestry to Saudi Arabia where a founder C12orf57 mutation is among the most common recessive causes of intellectual disability.

KW - C12orf57

KW - colobomav

KW - global developmental delay

KW - Temtamy syndrome

UR - http://www.scopus.com/inward/record.url?scp=85041221493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041221493&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.38615

DO - 10.1002/ajmg.a.38615

M3 - Article

AN - SCOPUS:85041221493

VL - 176

SP - 715

EP - 721

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -